U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863805) titled 'Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas' on Jan. 10.
Brief Summary: The study is aimed at all adult patients diagnosed with advanced thyroid carcinomas and well-differentiated thyroid carcinomas (DTC) iodine-refractory, well-differentiated iodine-refractory thyroid (RAI-R DTC) metastatic carcinomas that are candidates for systemic therapy. By simple blood sampling and analysis on peripheral blood of circulating DNA (ccf-DNA), circulating RNA (ccf-RNA), and counting and analysis of circulating tumor cells through the use of liquid biopsy, molecular profiling corresponding to those o...